0 of 15 questions completed
Questions:
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
Time has elapsed
Name:
This response will be reviewed and graded after submission.
Title:
This response will be reviewed and graded after submission.
City, state:
This response will be reviewed and graded after submission.
Institution:
This response will be reviewed and graded after submission.
Credentials (choose highest level applicable):
Please specify your role in naxitamab therapy (i.e. infusion nurse, educator, prescriber, administrator):
This response will be reviewed and graded after submission.
Are you involved in acute care of patients with neuroblastoma?
Are you involved in critical care of patients with neuroblastoma?
Years of experience with anti-GD2 therapy:
This response will be reviewed and graded after submission.
Years of experience with critical care:
This response will be reviewed and graded after submission.
Years of experience with inpatient:
This response will be reviewed and graded after submission.
Years of experience with outpatient:
This response will be reviewed and graded after submission.
Have you participated in LIVE anti-GD2 therapy training before?
Have you participated in ONLINE anti-GD2 therapy training before?
Have you participated in any OTHER anti-GD2 therapy training before?
This response will be reviewed and graded after submission.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.